LYmphocyte ACtivaTion and Signaling. Team leader Dr Thierry Walzer

Lyon, FRANCE
Joined May 2020
📢 SAVE THE DATE! RHUMATOPEDIES 2024 is coming 📅Wednesday 4th December 2024 📌 University of Lyon, 69007 LYON 👨‍⚕️ Lecture by Prof. Daniel Kastner, MD, PhD 📝 Registration: lnkd.in/emX8Pn8T 📰 Scientific Programme below
4
2
5
2,811
6 novel monoallelic PTPN2 mutations in pediatric lupus and Evans syndrome that cause T cell hyperproliferation and high inflammatory cytokines @JExpMed doi.org/10.1084/jem.20240980 @MACattackLab comment doi.org/10.1084/jem.20232337 @AlexandreBelot @FRLab1 #Mathieu
1
36
151
14,293
Very proud to share my first paper on my thesis project, a great collaborative effort between @CIRI_Lyon and @InstitutImagine, now published in @JExpMed. Check it out!
Jeanpierre, Cognard, @FRLab1, @AlexandreBelot, Mathieu @CIRI_Lyon et al. performed exome sequencing in pediatric systemic #lupus and Evans syndrome and identified six novel monoallelic PTPN2 mutations, impairing its regulatory function. hubs.la/Q02HrHBb0 #autoimmunity
2
5
15
2,173
LYACTS-CIRI retweeted
Honored to have been part of this beautiful collaboration with @JEANPIERRMarie from @FRLab1 team in @InstitutImagine for my very first steps in the lab, thanks to @lyacts, @MaudTusseau @AlexandreBelot and Anne-Laure Mathieu ! ✨´
Jeanpierre, Cognard, @FRLab1, @AlexandreBelot, Mathieu @CIRI_Lyon et al. performed exome sequencing in pediatric systemic #lupus and Evans syndrome and identified six novel monoallelic PTPN2 mutations, impairing its regulatory function. hubs.la/Q02HrHBb0 #autoimmunity
1
10
687
Thrilled to share our work on PTPN2 mutations in autoimmunity. Congratulations to all authors on this beautiful study! A great collaborative effort between @FRLab1 team at @InstitutImagine and @AlexandreBelot's team at @lyacts @CIRI_Lyon @CgdJade @MaudTusseau @ALMathieu277161
Jeanpierre, Cognard, @FRLab1, @AlexandreBelot, Mathieu @CIRI_Lyon et al. performed exome sequencing in pediatric systemic #lupus and Evans syndrome and identified six novel monoallelic PTPN2 mutations, impairing its regulatory function. hubs.la/Q02HrHBb0 #autoimmunity
8
153
Excellent review on monogenic SLE: link.springer.com/article/10…
3
15
1
77
10,025
Mendelian causes of autoimmunity -> the #lupus phenotype! A fascinating (disease) syndrome #IEI, #RareDisease #Genetics with @MaudTusseau @SamiraPlassart @CgdJade @SarahBenezech @LilianeKhoryati @Seb_Viel @FRLab1 @lyacts, Still so much left to uncover.
9
24
2,191
LYACTS-CIRI retweeted
Ce 29 février, c'est le #RareDiseaseDay2024. Au CIRI, les équipes I2BA (T. Henry) et LYACTS (T. Walzer) étudient des maladies rares auto-immunes et auto-inflammatoires. Un grand merci aux cliniciens qui font avancer la recherche, et aux patient/es !
3
6
377
LYACTS-CIRI retweeted
❔Quel est le lien entre cancer et système immunitaire ? Thierry Walzer, directeur de recherche @Inserm et chef de l'équipe @lyacts, l'explique dans l'émission #TêtesChercheuses, dont voici un extrait 👇 Retrouvez l'émission complète ici ➡ youtube.com/watch?v=B2N9133c…
Thierry Walzer porte un projet financé par la Fondation ARC qui vise à mieux comprendre les liens entre cancer et vieillissement du système immunitaire. Il est revenu pendant l'émission Têtes Chercheuses sur le rôle du système immunitaire. L'émission : ow.ly/88sC50QzC6z
1
4
450
🔬 🌐 Check out our comment on drug development in ultra-rare diseases in @TheLancet, spotlighting promising results of a new C5 inhibitor via SC route for CD55 deficiency. 🩺 #RareDiseases #MedicalBreakthrough"thelancet.com/journals/lance… ⤵️
2
2
14
1,119
LYACTS-CIRI retweeted
Fascinating paper on pre-covid possible MIS-C with implications for understanding pathogenesis. Congrats Alex Belot and team. Pre–Covid-19, SARS-CoV-2–Negative Multisystem Inflammatory Syndrome in Children | NEJM nejm.org/doi/full/10.1056/NE…
1
5
7
701
Fantastic research day at Rhumatopedies 2023, the 10th edition that welcome in Lyon many talented young researchers in the field of Pediatric Immunology/rheumatology & Incredible talk of our guest @BrodinPetter! Thanks for coming
3
4
3
27
4,820
History of a success: exciting science, friendship and Cuisine Lyonnaise. @BrodinPetter #Rhumatopedies2023
1
3
748
Sometimes groundbreaking research means demonstrating there nothing new but we missed it before! 'Old' Coronaviruses were triggering MIS-C in children before #SARSCoV2 👇👇👇 #pandemicpreparedness
A study suggests that prepandemic and SARS-CoV-2–negative cases that are indistinguishable from MIS-C are characterized by Vβ21.3+ T-cell expansion and may be triggered by other pathogens. Read the full correspondence: nej.md/49SwOTT

1
5
12
1,166
Beautiful work from @AlexandreBelot and team on MIS-C assigned to the pre-COVID area, including TCR Vb21.3 expansion! xitter.cf/NEJM/status/1729996157…
A study suggests that prepandemic and SARS-CoV-2–negative cases that are indistinguishable from MIS-C are characterized by Vβ21.3+ T-cell expansion and may be triggered by other pathogens. Read the full correspondence: nej.md/49SwOTT

1
2
1
7
811
MIS-C existed pre-COVID? See this report from @AlexandreBelot and colleagues. Time to re-think about Kawasaki disease and other post-infectious inflammatory conditions.
A study suggests that prepandemic and SARS-CoV-2–negative cases that are indistinguishable from MIS-C are characterized by Vβ21.3+ T-cell expansion and may be triggered by other pathogens. Read the full correspondence: nej.md/49SwOTT

3
8
1
20
4,014
LYACTS-CIRI retweeted
Correspondence: Pre–Covid-19, SARS-CoV-2–Negative Multisystem Inflammatory Syndrome in Children nej.md/49SwOTT #Pediatrics

2
16
1
42
36,228
COVID-19 : le syndrome inflammatoire multi-systémique de l’enfant (PIMS) existait avant la pandémie teamhcl.chu-lyon.fr/covid-19… @CHUdeLyon @CIRI_Lyon (@UnivLyon1 @ENSdeLyon @InsermAuRA @CNRS_dr07)
Thrilled to share our paper in @NEJM on pre-COVID and SARS-CoV-2 negative MIS-C. This condition predates the pandemic but was incredibly rare and often misdiagnosed as Kawasaki Disease Shock Syndrome or Toxic Shock Syndrome without identified bacteria nej.md/49SwOTT 🧵
5
10
1,558
LYACTS-CIRI retweeted
A study suggests that prepandemic and SARS-CoV-2–negative cases that are indistinguishable from MIS-C are characterized by Vβ21.3+ T-cell expansion and may be triggered by other pathogens. Read the full correspondence: nej.md/49SwOTT

5
20
3
54
36,993
Thrilled to share our paper in @NEJM on pre-COVID and SARS-CoV-2 negative MIS-C. This condition predates the pandemic but was incredibly rare and often misdiagnosed as Kawasaki Disease Shock Syndrome or Toxic Shock Syndrome without identified bacteria nej.md/49SwOTT 🧵
21
40
8
118
21,340